Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2024-11-20 Major Shareholding Noti…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Major shareholder disclosure in Navamedic ASA
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Standard form for notification of major holdings". It details the acquisition or disposal of voting rights by 'Skandinaviska Enskilda Banken' in 'Navamedic ASA', crossing a threshold (12.516%). This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the definition of a Major Shareholding Notification.
2024-11-20 English
Major shareholder disclosure in Navamedic ASA
Major Shareholding Notification Classification · 98% confidence The document text is extremely short (137 characters) and explicitly states, "Major shareholder disclosure in Navamedic ASA" followed by instructions to "Please see attachment on www.newsweb.no". This structure indicates that the document itself is merely an announcement pointing to the actual disclosure document elsewhere. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement pointing to an attachment or external link should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is a specific type of disclosure (Major shareholder), and RNS is the general regulatory fallback, I will check if 'Major Shareholding Notification' (MRQ) fits. MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. This announcement directly relates to a major shareholder disclosure. Given the brevity and the nature of the content (a notification about a major shareholder change), MRQ is the most specific and appropriate classification, even though it is an announcement pointing elsewhere, as MRQ covers the notification itself.
2024-11-20 English
Flaggemelding Navamedic (NAVA)
Major Shareholding Notification Classification · 98% confidence The document is titled "Flaggemelding Navamedic (NAVA)" which translates to a Flagging Announcement or Major Shareholding Notification in a Norwegian context. The text explicitly states that Kistefos AS purchased a significant number of shares, resulting in an ownership stake of 12.52%. This action triggers a mandatory disclosure regarding changes in significant share ownership thresholds. This aligns directly with the definition of Major Shareholding Notification (MRQ). The document is very short, but its content is a direct notification of a transaction impacting ownership percentage, not just an announcement that a report is available.
2024-11-19 Norwegian
Navamedic ASA: Amendments to loan agreements with Observe Medical ASA
Capital/Financing Update Classification · 99% confidence The document announces specific amendments to loan agreements between Navamedic ASA and Observe Medical ASA, including the postponement of maturity dates and a conditional conversion of debt into shares. This type of corporate action, which involves changes to financing terms and capital structure (debt-to-equity conversion), falls under financing activities. The text explicitly mentions that the announcement contains information considered inside information pursuant to EU Market Abuse Regulation and is subject to disclosure requirements, indicating it is a formal regulatory disclosure. Since it details a significant change in financing/capital structure rather than just a general earnings release or a standard annual report, the most appropriate category is 'Capital/Financing Update' (CAP). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a simple announcement of a report (RPA).
2024-11-15 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing Classification · 100% confidence The document text is structured as a formal notification detailing a transaction involving shares by a person discharging managerial responsibilities (Primary insider: CFO, Lars Hjarrand). Specifically, it reports that the CFO 'Bought shares' (20,000 shares at NOK 23.80) on 6.11.2024. This perfectly matches the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2024-11-06 English
Navamedic ASA: Mandatory notice of trade
Director's Dealing Classification · 100% confidence The document is titled 'Navamedic ASA: Mandatory notice of trade' and explicitly states that the CFO, a primary insider, bought shares. It references disclosure requirements under the Market Abuse Regulation (MAR) Article 19. This content directly corresponds to the reporting of personal share transactions by company directors and executives, which matches the definition for Director's Dealing (DIRS). The document length is very short (691 chars), but the content is a direct disclosure of a trade, not an announcement of a report, making DIRS the most specific fit over RNS.
2024-11-06 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.